To the full analysis
HNI stock: growth
HNIHNI reported $2.84B in revenue for fiscal 2025, up 12.4% on the prior year, up 7.7% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
0.3%
per year from 2006 to 2025, per share 0.5%
Earnings (Annual rate)
−4.2%
per year from 2006 to 2025, per share −4%
Free cash flow (Annual rate)
4%
per year from 2006 to 2025, per share 4.2%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 7.7% | 2.1% | 0.3% |
| Revenue per share | 5.3% | 1.3% | 0.5% |
| Earnings | 5.3% | −6.4% | −4.2% |
| Earnings per share | 2.9% | −7.2% | −4.0% |
| Free cash flow | 2.9% | 8.8% | 4.0% |
| Free cash flow per share | 0.6% | 7.9% | 4.2% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $2.68B | $123.38M | $100.68M |
| 2007 | $2.57B | $120.38M | $232.62M |
| 2008 | $2.48B | $45.45M | $104.29M |
| 2009 | $1.66B | −$6.44M | $175.65M |
| 2010 | $1.69B | $26.94M | $68.7M |
| 2011 | $1.83B | $45.99M | $106.48M |
| 2012 | $2B | $48.97M | $105.3M |
| 2013 | $2.06B | $63.68M | $104.03M |
| 2014 | $2.22B | $61.47M | $93.47M |
| 2015 | $2.3B | $105.44M | $90.74M |
| 2016 | $2.2B | $85.58M | $129.94M |
| 2017 | $2.18B | $89.8M | $23.91M |
| 2018 | $2.26B | $93.38M | $130.78M |
| 2019 | $2.25B | $110.51M | $158.55M |
| 2020 | $1.96B | $41.9M | $182.17M |
| 2021 | $2.18B | $59.8M | $78.17M |
| 2022 | $2.36B | $123.9M | $21.2M |
| 2023 | $2.43B | $49.2M | $189.4M |
| 2024 | $2.53B | $139.5M | $176.1M |
| 2025 | $2.84B | $54.2M | $210.4M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 3 Jan 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.